2025 annual financial data
PDS Biotechnology 2025 Operating margin
PDS Biotechnology 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -31,543,959 USD and net income was -34,495,505 USD.
Operating cash flow was -27,752,012,000 USD.
Get free PDS Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -31,543,959 USD
- Net income
- -34,495,505 USD
- Operating cash flow
- -27,752,012,000 USD